Clinical Trial Detail

NCT ID NCT03709758
Title Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naive AML
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

acute myeloid leukemia

Therapies

Cytarabine + Daunorubicin + Venetoclax

Age Groups: adult senior

Additional content available in CKB BOOST